Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Covalent Tolerance Induction to Factor VIII-Prediction of Inhibitors in Hemophilia

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Miguel Escobar, The University of Texas Health Science Center, Houston
ClinicalTrials.gov Identifier:
NCT00178607
First received: September 12, 2005
Last updated: May 10, 2016
Last verified: May 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2015
  Primary Completion Date: October 2015 (Final data collection date for primary outcome measure)